Jane Street »

Atrium Therapeutics shares owned by Jane Street

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Jane Street

Quarter filed Position value Share count Share price at filing
2026-03-31 $267k 20k 13.37

More positions owned by Jane Street

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Micron Technology Call Option (MU)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for Jane Street

Top funds holding Atrium Therapeutics

BlackRock
Susquehanna International
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Farallon Capital Management
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Bellevue Group
State Street Corporation
Weiss Asset Management LP[1

View all funds holding Atrium Therapeutics